Recombinant DNA Technology Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Medical, Non-medical), By Component (Expression System), By Application, By End Use, And Segment Forecasts

Market Segmentation

Recombinant DNA Technology Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Medical
  - Therapeutic Agent
  - Human Protein
  - Vaccine
- Non-medical
  - Biotech Crops
  - Specialty Chemicals
  - Other Non-medical Products
Recombinant DNA Technology Component Outlook (Revenue, USD Billion, 2018 - 2030)
- Expression System
  - Mammalian
  - Bacteria
  - Yeast
  - Baculovirus / Insect
  - Other Expression Systems
- Cloning Vector
Recombinant DNA Technology Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Food & Agriculture
- Health & Disease
  - Human
  - Animal
- Environment
- Other Applications
Recombinant DNA Technology End Use Outlook (Revenue, USD Billion, 2018 - 2030)
- Biotechnology and Pharmaceutical Companies
- Academic & Government Research Institutes
- Other End Uses
Recombinant DNA Technology Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - U.S.
  - Canada
  - Mexico
- Europe
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - Denmark
  - Sweden
  - Norway
- Asia Pacific
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - Thailand
- Latin America
  - Brazil
  - Argentina
- Middle East & Africa
  - South Africa
  - Saudi Arabia
  - UAE
  - Kuwait

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments